All Resources

During the BR1DGE Symposium at the European Association for the Study of Diabetes (EASD) 2025 congress titled “A New Dawn in T1D: How Early Screening and Intervention Could Light the Way to Improved Clinical Outcomes”, experts discussed the importance of early detection in the management of autoimmune type 1 diabetes (T1D), risk factors for T1D, and different investigational therapeutic strategies in Stage 3 T1D.

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform.  

An expert discussion on presymptomatic T1D, with a focus on early detection, monitoring, and management, featured in a North European webinar (October 2025).

This is a practical guide to establishing islet autoantibody screening programs 

Partha Kar talks to Jurgen Vercauteren, a T1D researcher living with T1D, about the challenges and benefits of screening for early-stage T1D  

Partha Kar talks to Mike Natter, an endocrinologist with type 1 diabetes, about how art and social media can be leveraged to engage and educate the wider diabetes community.

Partha Kar talks to Alice Cheng about how to correctly diagnose adult-onset type 1 diabetes, including the role of clinical tools such as the AABBCC criteria and IAb testing.

A short video from EASD 2025 exploring learnings from implementation of population-level T1D screening programs .

A short video of Professor Colin Dayan describing the current and potential future therapeutic options for managing T1D.

A short video of Professor Albanese O’Neil describing the benefits of early detection of T1D as discovered through early detection screening programs.

During the BR1DGE Symposium at the FIP 2025 titled “Shifting the Paradigm: Innovations in T1D Screening and Pharmacist-Led Management”, experts discussed the progression and staging and challenges of autoimmune Type 1 Diabetes, as well as the role of pharmacists as a vital member in the interprofessional care team involved in early detection within community pharmacy settings.

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform
 

Partha Kar talks to Steve Edelman, founder of Taking Control Of Your Diabetes, about the role of TCOYD in education and outreach. 

Partha Kar talks to Ezio Bonifacio about the role of islet autoantibody screening programs for the detection of early-stage type 1 diabetes